Colossyan vs PixVerse affiliate programs
Colossyan and PixVerse are AI video tools that both run affiliate programs. Colossyan lists 25%-50% through Rewardful; PixVerse lists 30% recurring for 12 months (35% Super Affiliate tier) through Impact. Both list a 90-day referral cookie. aifilliate records each program from a cited vendor source and does not rank the two.
| Recorded term | Colossyan Verified | PixVerse Verified |
|---|---|---|
| Commission | 25%-50% | 30% recurring for 12 months (35% Super Affiliate tier) |
| Structure | Recurring | Recurring |
| Cookie window | 90 days | 90 days |
| Network | Rewardful | Impact |
| Payout threshold | Not stated | Not stated |
| Terms checked | 2026-08-21 | 2026-08-22 |
| Source | Open source ↗ | Open source ↗ |
What matches, what differs
Differences
- Different platforms: Rewardful against Impact, meaning two dashboards and two payout schedules.
In common
- Both are AI video tools.
- Both pay recurring commission.
- Both list a 90-day referral cookie.
What these terms mean in practice
Promoting both means two applications, two dashboards, and two payout schedules — Rewardful for Colossyan and Impact for PixVerse, each with its own approval and its own minimum.
What is not published
Anything below has to be confirmed with the vendor before either offer can be modelled. aifilliate records it as unknown rather than estimating it.
- Neither vendor publishes a payout threshold.
How to read these two records
Both rates are stated as percentages of customer payments, so the figures share a basis. They may still cover different plans, billing terms, and eligibility rules.
Both pay recurring commission. Both list a 90-day referral cookie.
aifilliate publishes no ranking between Colossyan and PixVerse. Which program earns more depends on plan price, conversion rate, retention, and refund reversals in your own audience — none of which appear in published affiliate terms. Confirm eligibility, paid-search and trademark rules, and payout timing with each vendor before promoting either.